LBRX
LB Pharmaceuticals Inc
43.00$
+1.2%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 99.9% | 86.1% | 98.6% | |
| 99.6% | 32.8% | 68.5% | 79.9% | |
| 99.6% | 94.8% | 83.5% | 94.3% | |
| 234.1% | 175.5% | 382.0% | 3.7% | |
| 2.2% | 5.7% | 24.2% | 2.4% | |
| – | – | 1.5% | 0.2% | |
| 0.7% | 3.0% | 6.9% | 0.7% | |
| 112.4% | – | – | – | |
| -134.1% | -75.5% | -282.0% | 96.3% | |
| -162.6% | -90.3% | -311.1% | -41.4% | |
| 16.5% | 7.8% | 10.6% | 8.1% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.